A5040048105- Congenital Heart Disease Studies
- Cardiac Arrhythmias and Treatments
- Cancer Immunotherapy and Biomarkers
- Cytokine Signaling Pathways and Interactions
- Psoriasis: Treatment and Pathogenesis
- Cardiac Valve Diseases and Treatments
- Pulmonary Hypertension Research and Treatments
- Mechanical Circulatory Support Devices
- CAR-T cell therapy research
- Cardiac pacing and defibrillation studies
- Central Venous Catheters and Hemodialysis
- Skin Protection and Aging
- Infective Endocarditis Diagnosis and Management
- Aortic Disease and Treatment Approaches
- Atrial Fibrillation Management and Outcomes
- Blood Coagulation and Thrombosis Mechanisms
- Vascular Anomalies and Treatments
- Cardiovascular and Diving-Related Complications
- Cardiac Imaging and Diagnostics
- Venous Thromboembolism Diagnosis and Management
- Vascular Procedures and Complications
- Vascular anomalies and interventions
- Coronary Artery Anomalies
- Transplantation: Methods and Outcomes
- Vascular Malformations Diagnosis and Treatment
Texas Children's Hospital
2016-2024
Baylor College of Medicine
2012-2024
GIFT University
2022
Bahauddin Zakariya University
2022
University of Education
2022
University of Okara
2022
Ghazi University
2022
Wayne State University
2010-2021
Institute of Business Management
2019
Children's Hospital of Michigan
2010-2011
Abstract Objective Comparison of outcomes using bare metal (BMS) and drug‐eluting (DES) stents in pulmonary vein stenosis (PVS). Background PVS is a serious condition with frequent restenosis after surgical percutaneous interventions. After experiencing encouraging results DES, we sought to compare BMS DES native post‐surgical PVS. Methods Results A retrospective review all patients who underwent stent implantation between 08/93 11/17 for at Texas Children's Hospital was performed. were used...
Abstract Background Transcatheter right ventricle decompression in neonates with pulmonary atresia and intact ventricular septum is technically challenging, risk of cardiac perforation death. Further, despite successful decompression, re-intervention on the valve common. The association between technical factors during risks complications are not well described. Methods This a multicentre retrospective study among participating centres Congenital Catheterization Research Collaborative....
Background Vascular thromboses are a significant cause of morbidity and mortality in children. Data children regarding catheter‐based rheolytic aspiration thrombectomy systems limited. We sought to review the safety efficacy Methods: all having undergone using specialized or were reviewed. Results: Thrombectomy was performed 50 vessels 21 patients, median age 1.9 months (8 days–18 yrs), weight 4.3 (1.1–67.9) kg. AngioJet 16, Helix Clot Buster 5, Fetch catheter 8, Pronto 1, combination other...
Long-term follow-up after stent dilation of native and acquired pulmonary artery stenosis is scarce in the pediatric population. Most cohorts include a myriad anatomies associated conditions.In order to establish objective performance criteria, we performed retrospective review all patients who underwent unilateral stenting biventricular physiology at three centers from June 2006 2011.Fifty-eight received 60 stents with Palmaz Genesis used most commonly (78%). Average age implantation was...
To describe our initial experience with pediatric transcatheter aortic valve replacement.Transcatheter replacement (TAVR) has been approved and used to treat calcific stenosis in adult patients. Select patients congenital heart disease (CHD) who are poor candidates for conventional surgical can benefit from TAVR.A retrospective review was performed identify CHD underwent or hybrid using a Melody Valve (Medtronic, Minneapolis, MN), Sapien S3/XT (Edwards Life sciences LLC, Irvine, CA)....
Early clinical outcomes data for adjunctive systemic sirolimus therapy (SST) moderate to severe pediatric pulmonary vein stenosis (PVS) are promising but limited. The authors aimed characterize a cohort of patients treated with SST determine if was associated reduction in frequency PVS interventions. Medical records 45 ≥1 month from 2015 2022 were retrospectively reviewed. intervention rates pre-SST and on-SST compared using generalized Poisson mixed models, accounting paired intervals...
United States approval of the Model 3830, 4.1-French (Fr) diameter, lumenless, pacing lead (Medtronic Inc., Minneapolis, MN, USA) in patients under 17 years age, and those with congenital heart disease (CHD), was 2005. To date, long-term performance at alternative sites (APS) is limited chronic efficacy comparisons more established leads lacking. The purpose this study to evaluate these factors.Implant follow-up data on were compared: group 1 (non-3830 leads) 2 (Model 3830 leads). These...
Pediatric pulmonary vein stenosis (PVS) is often progressive and treatment-refractory, requiring multiple interventions. Hybrid interventions (HPVIs), involving intraoperative balloon angioplasty or stent placement, leverage surgical access customization to optimize patency while facilitating future transcatheter procedures. We review our experience with HPVI explore potential applications of this collaborative approach.
Background: Pediatric pulmonary vein stenosis (PVS) has a guarded prognosis and often necessitates repeated interventions. Small retrospective studies suggest benefits to adjunctive enteral systemic sirolimus therapy (SST) for PVS, including improved survival, slowed progression of in-stent stenosis, reduced frequency catheterization procedures. Hypothesis: We hypothesized patients undergo PVS interventions less frequently while receiving SST compared pre-SST. Aims: The principal aim was...
Abstract Background Tricuspid valve injury can occur during implantation of a SAPIEN in the pulmonary position. We describe our experience using long Gore DrySeal (GDS) sheath to protect tricuspid advancement Commander delivery system. Methods Retrospective single center review all patients who underwent placement right ventricular outflow tract between January 2016 and April 2020. Patients were divided into two groups: standard technique (Group I), with use GDS II), for comparison. Results...
The removal of balloon fragments from the pulmonary artery without damaging and tricuspid valves can be difficult. Four cases during transcatheter valve replacement are described in which a novel retrieval system was used to facilitate safe removal. (
Fontan baffle punctures and creation of fenestration for cardiac catheterisation procedures remain challenging especially due to the heavy calcification prosthetic material complex anatomy.We sought evaluate our experience using radiofrequency current via surgical electrocautery needle puncture facilitate diagnostic, electrophysiology, interventional procedures.A retrospective chart review all patients (pts) who underwent energy from three centres were performed January 2011 July 2021.A...
The data on the use of Gore Cardioform Septal Occluder (GCA; W. L. and Associates, Inc.) for atrial septal defect (ASD) with deficient rims is limited.All patients evaluated by transesophageal echocardiogram (TEE) ASD occlusion were included. TEE planes at 35°, 0°, 90° assessed anterior-superior (AS) posterior (P), anterior-inferior (AI) posterior-superior (PS), as well superior (S) inferior (I) rims. size >20 mm, less than 5 mm defined large deficient, respectively. We included who had a...
Abstract Pulmonary artery banding (PAB) is used to restrict pulmonary blood flow in select patients with large left-to-right intracardiac shunts or unrestrictive prior eventual surgical repair palliation. More recently, placement of an internal intraluminal PAB (IPAB) has been circulation. Here we present two who underwent balloon angioplasty the IPAB treat cyanosis and improve flow.
Abstract Background: Hepatic and splenic venous access are specialised techniques used to perform diagnostic interventional procedures in the cardiac catheterisation laboratory. Bleeding events most commonly reported complication following hepatic or access. The VASCADE Vascular Closure System (Cardiva Medical Inc. Santa Barbara, CA) is an approved device for closure of femoral vascular tracts patients ≥18 years age. We report our experience using close site Methods: This a single centre...